Mystery chest pain: study digs deeper to find hidden heart problems
NCT ID NCT05288361
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involves 500 people who have chest pain or other signs of heart trouble, but whose main heart arteries are not blocked. Researchers use special tools during a heart catheterization to measure tiny blood vessel function and look for hidden causes like microvascular disease or spasms. The goal is to better understand these conditions and track patients' health over time to improve diagnosis and treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 500 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2022
- Expected to finish
-
Dec 2032
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults referred to the catheterization laboratory for evaluation of suspected ischemic heart disease, and who are deemed to have non-obstructive coronary artery disease based on coronary angiography or non-ischemic fractional flow reserve (FFR) or resting free cycle ratio (RFR).
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Suspected ischemic heart disease and is referred to undergo clinically indicated invasive coronary angiography * No obstructive coronary artery disease (CAD) as defined by operator visual assessment with (1) angiographically normal coronary arteries OR (2) non-obstructive CAD with angiographic stenosis \< 50%, or greater than or equal to 50 but \< 70% with FFR greater than or equal to 0.81 or RFR greater than or equal to 0.90 * Willing to comply with specified follow-up evaluations. The participant or legally authorized representative has been informed of the nature of the study, agrees to its provisions, and has been provided written informed consent approved by the appropriate Institutional Review Board (IRB) or Ethics Committee (EC) Exclusion Criteria: * Pregnant or nursing * Any myocardial infarction at index presentation or within 90 days prior to enrollment, defined as any electrocardiogram diagnostic for myocardial infarction OR elevation in serum troponin greater than the upper limit of the site-defined reference range * Known left ventricular ejection fraction \< 50% or cardiogenic shock requiring pressors or mechanical circulatory assistance (e.g., intra-aortic balloon pump, left ventricular assist device, other temporary cardiac support blood pump) * Renal insufficiency, defined as estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73 m2 (by the Modification of Diet in Renal Disease equation) or dialysis at the time of screening * Prior percutaneous coronary intervention * Planned percutaneous coronary intervention (PCI) * Prior coronary artery bypass graft surgery * Prior ST-elevation myocardial infarction * History of hypertrophic cardiomyopathy * History of infiltrative heart disease (e.g., cardiac amyloidosis) * New York Heart Association Class IV congestive heart failure * Severe mitral regurgitation * Severe aortic stenosis * Severe pulmonary hypertension (Mean pulmonary artery pressure greater than or equal to 35mmHg or echocardiographic right ventricular systolic pressure greater than or equal to 60mmHg) * Known history of unrepaired or repaired congenital heart disease * Past or pending heart transplant, or on the waiting list for organ transplant * Known other medical illness or known history of substance abuse that may cause non-compliance with the protocol, or is associated with a life expectancy of less than 1 year * Current or planned participation in a study of an investigational therapy * Angiographic stenosis in any major epicardial vessel ≥ 70% by visual estimate * Angiographic stenosis in any major epicardial vessel greater than or equal to 50% and \< 70% by visual estimate with FFR less than or equal to 0.80 or RFR less than or equal to 0.89
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chest pain with normal coronary angiography are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
NYU Langone Health
New York, New York, 10010, United States
-
New York Presbyterian-Brooklyn Methodist Hospital
Brooklyn, New York, 11215, United States
-
Northeast Georgia Medical Center
Gainesville, Georgia, 30501, United States
-
Stanford Hospital
Stanford, California, 94305, United States
-
The Christ Hospital
Cincinnati, Ohio, 45219, United States
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
-
UCLA Health
Los Angeles, California, 90095, United States
-
Yale New Haven Hospital
New Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Plant-Based diet restore blood flow in the Heart's small vessels?
- Can a diabetes drug shield aging blood vessels?
- A natural supplement combo could give hearts a boost
- Can tiny heart vessel damage predict heart failure?
- Ancient herbal mix may shield blood vessels in diabetes
- Could a vitamin B3 pill undo early heart damage from childhood adversity?